Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.28
+0.35 (7.10%)
Aug 19, 2026, 3:28 PM EDT - Market open
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $433.18 million as of August 19, 2026. Its market cap has increased by 63.06% in one year.
Market Cap
433.18M
Enterprise Value
228.29M
1-Year Change
63.06%
Ranking
Category
Stock Price
$5.28
ChartMarket Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $433.18M, an increase of 59.64%. That is a compound annual growth rate of 18.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 433.18M | -40.23% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 418.40M |
| Fennec Pharmaceuticals | 410.99M |
| Atea Pharmaceuticals | 410.65M |
| Compass Therapeutics | 405.20M |
| ProKidney | 402.09M |
| Scribe Therapeutics | 391.06M |
| Upstream Bio | 387.23M |
| Capricor Therapeutics | 386.62M |